Cell-cycle inhibitory effects of the mitotic inhibitor NY 3170 on human cells in vitro
Related Experiment Videos
Abstract:
Effects of the mitotic inhibitor NY 3170 (1-propargyl-5-chloropyrimidin-2-one) on cell-cycle kinetics of NHIK 3025 cells were studied by means of time-lapse microcinematography, pulsed incorporation of [3H] thymidine, flow cytometry, and mitotic index. All the experiments were performed with cells synchronized by mitotic selection. Mitotic inhibition as well as inhibition in interphase was examined. The small fraction of cells able to escape mitotic arrest at 0.2mM NY 3170 had spent about 12 h in metaphase. The metaphase block was complete at 0.3 mM. For comparison, complete metaphase arrest of NHIK 3025 cells was reached at 8 mM after treatment with the parent substance NY 3000 (5-chloropyrimidin-2-one, previously reported). At 0.3mM NY 3170 interphase was also considerably prolonged. All stages of interphase were prolonged, in contrast to the interphase prolongation after treatment with high concentrations of the mitotic inhibitors vincristine and vinblastine, which occurs in G2. It was shown that the presence of NY 3170 during mitosis is a necessary and sufficient condition for metaphase arrest, thus demonstrating that metaphase arrest is not dependent on some preceding event in interphase.
Insights
The mitotic inhibitor NY 3170 effectively halts cell division by arresting cells in metaphase, a process not dependent on prior interphase events. This compound significantly prolongs interphase stages in NHIK 3025 cells.
Area of Science:
- Cell biology
- Molecular pharmacology
- Cancer research
Background:
- Understanding cell-cycle regulation is crucial for developing targeted cancer therapies.
- Mitotic inhibitors are vital tools for studying cell division and potential chemotherapeutics.
- NY 3170 is a novel mitotic inhibitor derived from 5-chloropyrimidin-2-one.
Purpose of the Study:
- To investigate the effects of the mitotic inhibitor NY 3170 on the cell-cycle kinetics of NHIK 3025 cells.
- To determine the concentration-dependent effects of NY 3170 on mitosis and interphase.
- To elucidate the mechanism of metaphase arrest induced by NY 3170.
Main Methods:
- Time-lapse microcinematography for observing cell division.
- Pulsed incorporation of [3H] thymidine to track DNA synthesis.
- Flow cytometry to analyze cell-cycle distribution.
- Mitotic index assessment to quantify mitotic cells.
Main Results:
- NY 3170 induced a dose-dependent metaphase arrest in NHIK 3025 cells, with complete arrest at 0.3 mM.
- Cells escaping arrest at 0.2 mM NY 3170 spent approximately 12 hours in metaphase.
- NY 3170 significantly prolonged all interphase stages, unlike other mitotic inhibitors that primarily affect G2.
- Metaphase arrest was confirmed to be dependent solely on the presence of NY 3170 during mitosis.
Conclusions:
- NY 3170 is a potent mitotic inhibitor causing metaphase arrest in synchronized NHIK 3025 cells.
- The mechanism of metaphase arrest by NY 3170 is independent of preceding interphase events.
- NY 3170 exhibits distinct effects on interphase duration compared to vincristine and vinblastine.